Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisation (2022)

First Author: Richardson T
Attributed to:  Mendelian randomization to hypothesis-free causal inference funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1371/journal.pbio.3001547

PubMed Identifier: 35213538

Publication URI: http://europepmc.org/abstract/MED/35213538

Type: Journal Article/Review

Parent Publication: PLOS Biology

Issue: 2

ISSN: 1544-9173